ebomi
The catalogIssuersInsidersTapeLicence
Colour theme
Theme
Sign in
Insider · CIK 0001651844

Robinson James George

CIK 0001651844 Name as filed on the most recent filing

Filed as Robinson James George (91)

380 transaction lines · from 91 filings · filed 2015-09-08 to 2023-06-26 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

380 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2019-06-25 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 200 acquired 1.73 345.80 Form 4, filing 0001651844-19-000015
2019-06-20 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 9,000 acquired 1.77 15,918.30 Form 4, filing 0001651844-19-000014
2019-06-19 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 8,000 acquired 1.69 13,528.80 Form 4, filing 0001651844-19-000013
2019-06-18 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 8,900 acquired 1.67 14,880.80 Form 4, filing 0001651844-19-000012
2019-06-18 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 100 acquired 1.65 165.18 Form 4, filing 0001651844-19-000012
2019-06-13 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 8,000 acquired 1.42 11,344.00 Form 4, filing 0001651844-19-000011
2019-06-11 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 1,430 acquired 1.42 2,029.17 Form 4, filing 0001651844-19-000010
2019-06-11 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 1,300 acquired 1.45 1,885.00 Form 4, filing 0001651844-19-000010
2019-06-11 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 1,100 acquired 1.44 1,584.00 Form 4, filing 0001651844-19-000010
2019-06-11 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 900 acquired 1.48 1,332.00 Form 4, filing 0001651844-19-000010
2019-06-11 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 882 acquired 1.42 1,248.03 Form 4, filing 0001651844-19-000010
2019-06-11 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 701 acquired 1.51 1,058.51 Form 4, filing 0001651844-19-000010
2019-06-11 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 700 acquired 1.43 1,001.00 Form 4, filing 0001651844-19-000010
2019-06-11 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 500 acquired 1.49 745.00 Form 4, filing 0001651844-19-000010
2019-06-11 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 400 acquired 1.52 608.00 Form 4, filing 0001651844-19-000010
2019-06-11 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 300 acquired 1.54 462.00 Form 4, filing 0001651844-19-000010
2019-06-11 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 287 acquired 1.60 458.91 Form 4, filing 0001651844-19-000010
2019-06-11 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 200 acquired 1.53 306.00 Form 4, filing 0001651844-19-000010
2019-06-11 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 200 acquired 1.42 284.00 Form 4, filing 0001651844-19-000010
2019-06-11 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 100 acquired 1.47 147.00 Form 4, filing 0001651844-19-000010
2019-06-10 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 8,000 acquired 1.54 12,288.00 Form 4, filing 0001651844-19-000009
2019-06-06 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 5,201 acquired 1.59 8,269.59 Form 4, filing 0001651844-19-000008
2019-06-06 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 1,100 acquired 1.53 1,683.00 Form 4, filing 0001651844-19-000008
2019-06-06 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 1,000 acquired 1.52 1,520.00 Form 4, filing 0001651844-19-000008
2019-06-06 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 800 acquired 1.55 1,240.00 Form 4, filing 0001651844-19-000008
2019-06-06 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 799 acquired 1.54 1,230.46 Form 4, filing 0001651844-19-000008
2019-06-06 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 600 acquired 1.56 936.00 Form 4, filing 0001651844-19-000008
2019-06-06 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 400 acquired 1.53 611.20 Form 4, filing 0001651844-19-000008
2019-06-06 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 100 acquired 1.58 158.00 Form 4, filing 0001651844-19-000008
2019-06-05 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 7,537 acquired 1.56 11,757.72 Form 4, filing 0001651844-19-000007
2019-06-05 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 1,863 acquired 1.54 2,869.02 Form 4, filing 0001651844-19-000007
2019-06-05 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 1,000 acquired 1.55 1,550.00 Form 4, filing 0001651844-19-000007
2019-06-05 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 400 acquired 1.53 611.00 Form 4, filing 0001651844-19-000007
2019-06-05 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 200 acquired 1.52 305.00 Form 4, filing 0001651844-19-000007
2019-06-03 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 9,000 acquired 1.62 14,598.00 Form 4, filing 0001651844-19-000006
2019-05-31 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 8,600 acquired 1.59 13,674.00 Form 4, filing 0001651844-19-000005
2019-05-31 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 1,093 acquired 1.61 1,759.73 Form 4, filing 0001651844-19-000005
2019-05-31 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 300 acquired 1.60 480.00 Form 4, filing 0001651844-19-000005
2019-05-31 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 7 acquired 1.58 11.06 Form 4, filing 0001651844-19-000005
2019-05-30 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 7,700 acquired 1.76 13,552.77 Form 4, filing 0001651844-19-000004
2019-05-30 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 600 acquired 1.77 1,061.28 Form 4, filing 0001651844-19-000004
2019-05-30 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 100 acquired 1.77 176.75 Form 4, filing 0001651844-19-000004
2019-05-30 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 100 acquired 1.76 176.50 Form 4, filing 0001651844-19-000004
2019-05-28 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 9,000 acquired 1.68 15,097.50 Form 4, filing 0001651844-19-000003
2019-05-24 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 8,000 acquired 1.59 12,749.60 Form 4, filing 0001651844-19-000002
2019-05-23 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 7,500 acquired 1.55 11,656.50 Form 4, filing 0001651844-19-000001
2018-12-13 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 5,237 acquired 1.72 9,007.12 Form 4, filing 0001651844-18-000036
2018-12-12 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 6,000 acquired 1.71 10,285.20 Form 4, filing 0001651844-18-000035
2018-12-11 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 5,000 acquired 1.67 8,359.00 Form 4, filing 0001651844-18-000034
2018-12-10 Nymox Pharmaceutical Corp
NYMX 		P, Open-market purchase 7,500 acquired 1.62 12,132.00 Form 4, filing 0001651844-18-000033

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 380
  • Open-market sale 0
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Robinson James George, insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001651844

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.